Mr. Craig Mull reports

CIPHER PHARMACEUTICALS ANNOUNCES THE COMMENCEMENT OF OTCQX TRADING

Cipher Pharmaceuticals Inc.'s common shares are now trading on the OTCQX Best Market under the symbol CPHRF. The OTCQX Best Market is the highest market tier of over-the-counter markets, on which 12,000 United States and global securities trade. Trading on the OTCQX Best Market will enhance the visibility and accessibility of the company to U.S. investors. Cipher's common shares will continue to trade on the Toronto Stock Exchange under the symbol CPH.

"Today's announcement is an important milestone for Cipher. We have attracted more attention from investors in the United States recently, and our strategy to trade through a new OTCQX stock quotation will make it easier for investors in the world's largest capital market to purchase shares in Cipher," stated Craig Mull, interim chief executive officer.

The OTCQX Best Market is intended for established, investor-focused U.S. and international companies. To qualify for the OTCQX Best Market, companies must: meet prescribed financial standards; follow best practice corporate governance guidelines; and demonstrate compliance with applicable securities laws. Trading on the OTCQX Best Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.

U.S. investors can find current financial disclosure and trading statistics, including real-time Level 2 quotes, for Cipher on the OTC Markets website.

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early-to-late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America.